Latest / Neuro-Oncology: The Podcast

Residual tumor volume and survival after CCNU/TMZ in GBM
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.